CAJ | 학술논문

目的研究康复新液合并抗痨药物治疗肺结核的疗效。方法2009年8月~2012年6月我院确诊的69例肺结核患者随机分为治疗组和对照组，对照组采用标准结核化疗方案。治疗组标准结核化疗方案联合口服康复新液。结果治疗组患者临床症状明显改善、病灶明显减小，治疗质量高。结论康复新液治疗肺结核疗效较好，值得格床推广应用。
목적연구강복신액합병항로약물치료폐결핵적료효。방법2009년8월~2012년6월아원학진적69례폐결핵환자수궤분위치료조화대조조，대조조채용표준결핵화료방안。치료조표준결핵화료방안연합구복강복신액。결과치료조환자림상증상명현개선、병조명현감소，치료질량고。결론강복신액치료폐결핵료효교호，치득격상추엄응용。
Objective To discuss the effectiveness of using the Kangfuxin liquid to treat the pulmonary tuberculosis.[Methods] 69 patients were divided into two groups at random,control group treated with standard chemotherapy only , treatment group treated with standard chemotherapy and Kangfuxin liquid.[Results]Clinical symptoms improved significantly of patients in the treatment group, the lesion is reduced obviously, has good treatment effect.[Conclusion]Kangfuxin liquid have good effect to treat the pulmonary tuberculosis,worthy of clinical application.